FDA 483 - Maude Group Inc. - March 13, 2020

An FDA inspection of Maude Group Inc., a manufacturer in Brooklyn, NY, revealed significant deficiencies in its quality system. The firm failed to establish written procedures for critical operations including complaint handling, supplier management, incoming product acceptance, internal quality audits, and management review. These findings indicate a fundamental lack of basic quality system controls.